Special Populations for Repotrectinib

Release date: 2026-06-02 14:20:26     Recommended: 23

Special Populations for Repotrectinib

If you are pregnant or planning to become pregnant, you must inform your doctor. Repotrectinib may cause harm to an unborn baby. Women of childbearing potential must have a negative pregnancy test before starting treatment. During treatment and for at least 2 months after the last dose, effective non-hormonal contraception must be used. Note that hormonal contraceptives (such as birth control pills, injections, or patches) may not be effective during treatment with Repotrectinib. Discuss suitable contraceptive methods with your doctor. If you become pregnant or suspect you are pregnant during treatment, contact your doctor immediately. For male patients with female partners of childbearing potential, effective contraception should also be used during treatment and for 4 months after the last dose. In addition, breastfeeding is not allowed during treatment and for 10 days after the last dose, as it is unknown whether the drug passes into breast milk.

Medical Conditions and Drug Information to Disclose Before Treatment

Before starting Repotrectinib, you need to discuss all personal health conditions with your medical team in detail. Be sure to tell your doctor if you have any neurological disorders, lung or respiratory diseases other than lung cancer, or liver or kidney function problems. At the same time, you must list all medications you are taking, including prescription drugs, over-the-counter medicines, vitamins, and any herbal supplements. Because when Repotrectinib is taken with certain other drugs, they may affect each other's blood concentrations, leading to changes in efficacy or increased side effects. For example, some drugs may reduce the effectiveness of Repotrectinib or increase the risk of side effects. Keep a complete list of your medications and show it to your doctor or pharmacist each time you get a new medicine. The above is not all that needs to be discussed; you should actively raise any questions.

Precautions for Using Repotrectinib

Taking Repotrectinib exactly as prescribed by your doctor on time is crucial for treatment effectiveness. Because ROS1-positive lung cancer requires sustained drug concentrations to control the tumor, missing any dose may affect efficacy. To help you remember to take your medication, try the following practical tips: First, establish a fixed daily routine, take it at about the same time every day (e.g., 8 AM and 8 PM), or link taking the medication with daily activities like brushing your teeth. Second, set reminders, such as alarms on your phone or sticky notes in visible places. Third, use a pillbox labeled with days of the week to track daily dosing. Fourth, use a calendar or reminder app to record each completed dose. Fifth, always carry enough medication when traveling to avoid missing doses due to itinerary changes. If you miss a dose or vomit at any time after taking the medication, do not take an extra dose; just skip the missed dose and take the next dose at the regularly scheduled time. Never take two doses at once.